'Low Testing Will Make It Impossible To Make Containment Zones': Delhi High Court To Hear Tomorrow Plea Seeking Increase In RT-PCR Tests

The Delhi High Court will hear tomorrow an urgent application filed by Advocate Ankur Mahindro, concerning decline in the number of RT-PCR tests being conducted in the national capital. The plea alleges that in the last 4-5 days, RT-PCR tests being conducted by private laboratories have reduced, even when the positivity rates are at an all-time high of beyond 30%. "The disadvantage to low testing or delayed reports is bound to lead to more infection as it is impossible to make containment zones till the time news is received of people testing positive," it states. The matter was mentioned today before a Division Bench of Justices Vipin Sanghi and Rekha Palli which is hearing cases pertaining to the Covid-19 situation in Delhi. The intervention has been made in the case titled Rakesh Malhotra v. GNCTD . The applicant seeks a direction to all the laboratories to ramp up testing. "It is important that urgent directives are issued to all private laboratories to furnish before this Hon'ble Court, the number of RT-PCR tests conducted in the last 2 weeks and the time taken to deliver the said reports on an average, including detailed breakup of how much time is taken by ICMR to certify the reports," the plea states. When the matter was mentioned, Solicitor General Tushar Mehta asked the intervenor to share "best practices" that may be adopted by the Government in this regard. Accordingly, Mahindro suggested: Ramp up Testing ICMR and other concerned authorities to ensure more and more laboratories are being approved to conduct RT-PCR tests.Centre may issue Show Cause notices to all private laboratories in Delhi, directing to disclose their maximum capacities and the reasons why the said capacity is not being met.Centre may order that if any laboratory is found to be unreasonably rejecting to conduct tests, strict action shall be taken against them.Mobile testing vans, as adopted by the State of Maharashtra, be adopted in Delhi as well. Address shortage of RT-PCR Kits Centre may speed up the process of RT-PCR kits being imported by private laboratories, which are stuck in customs.State Government may earmark funds and import RT-PCR machines in order to ramp up testing at Government centres.Other strategies to ramp up testing of residents all across Delhi be used, like pooled testing, which allows laboratories to test more samples with fewer testing materials. It could be used in a scenario where workers of one workplace or one family can be tested together.As of today, apart from RT-PCR tests, private laboratories have started running short on testing kits of other tests related to COVID-19 like D-Dimer test, etc. Immediate steps to be taken in this regard as well to ensure that things may not spiral qua such tests as well. Handling of samples Ensure that samples being collected are handled with utmost care and the Phlebotomists be provided with appropriate ice boxes for carrying of samples. Reduce time taken to furnish testing reports A strict direction be issued to ICMR by the Central Government qua the time taken by the authority to certify the reports submitted by laboratories on its data entry portal. Alternatively, the said process of certification/verification may be automated and done immediately upon uploading of the report on its portal. Cap testing prices Mahindro suggestes that there is a need to take a look at the skyrocketing and exorbitant pricing that the private laboratories are asking today for RT-PCR and other tests related to COVID-19. Standard blood tests being prescribed by the doctors are easily amounting to approximately Rs. 15,000/-. A chest CT Scan, i.e., an HRCT is being charged at a minimum rate of Rs. 3,500/-, a test which is essential for keeping a check on the lungs of a COVID-19 patient.Directions may be passed by the Court or by the State Government so that more and more citizens can afford such tests.Note: The Court will also hear another application concerning acute shortage of Covid-19 medicines in Delhi, such as Remdesivir, Favipiravir, Fabiflu, Tocilizumab etc.Click Here To Download ApplicationClick Here To Download Best Practices

'Low Testing Will Make It Impossible To Make Containment Zones': Delhi High Court To Hear Tomorrow Plea Seeking Increase In RT-PCR Tests

Akshita Saxena

Tags